Robert J. Perez - 06 Mar 2023 Form 4 Insider Report for Third Harmonic Bio, Inc. (THRD)

Reporting relationship: Director
Issuer ticker: THRD
Reported as of: 06 Mar 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 08 Mar 2023, 16:06:06 UTC
Prior SEC filing: 27 Oct 2022
Next SEC filing: 24 May 2023
Source filing: View source filing
Reporting owner signature: /s/ Robert Ho, Attoney-in-Fact

Key filing fact

Robert J. Perez filed Form 4 for Third Harmonic Bio, Inc. (THRD) on 08 Mar 2023.

Key facts

This page summarizes Robert J. Perez's Form 4 filing for Third Harmonic Bio, Inc. (THRD).
2 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 08 Mar 2023, 16:06.

Change

Previous filing in this sequence was filed on 27 Oct 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

THRD transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -13,667
Change %: -100%
Price
Shares after: 0
Date: 06 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,667
Exercise price: $17.83
Footnotes: F1, F2

THRD transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +13,667
Change %
Price
Shares after: 13,667
Date: 06 Mar 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 13,667
Exercise price: $4.20
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The transaction reported herein reflects a one-time stock option repricing that became effective on March 6, 2023, and is being reported in this manner solely to comply with the technical reporting requirements under Section 16(a) of the Securities Exchange Act of 1934, as amended. There have been no other changes to the terms of these Options.

Footnote F2

The option vests over a 8-month period: 1/8th on October 26, 2022, after which 1/8th of the total shares vest monthly, subject to continued service through each vesting date.